These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16319906

  • 1. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress.
    Arosio E, De Marchi S, Prior M, Rigoni A, Lechi A.
    J Hum Hypertens; 2006 Mar; 20(3):201-5. PubMed ID: 16319906
    [Abstract] [Full Text] [Related]

  • 2. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 3. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 4. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    Fogari R, Zoppi A, Derosa G, Mugellini A, Lazzari P, Rinaldi A, Fogari E, Preti P.
    J Hum Hypertens; 2007 Mar; 21(3):220-4. PubMed ID: 17215848
    [Abstract] [Full Text] [Related]

  • 5. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
    Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M.
    J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279
    [Abstract] [Full Text] [Related]

  • 6. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S.
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S.
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [Abstract] [Full Text] [Related]

  • 8. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 9. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
    Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O.
    J Hypertens; 2006 Nov; 24(11):2163-8. PubMed ID: 17053536
    [Abstract] [Full Text] [Related]

  • 10. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 11. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A, Rahman AR, Rasool AH.
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [Abstract] [Full Text] [Related]

  • 12. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
    Fogari R, Derosa G, Ferrari I, Corradi L, Zoppi A, Lazzari P, Santoro T, Preti P, Mugellini A.
    Am J Hypertens; 2008 Sep; 21(9):1034-9. PubMed ID: 18566593
    [Abstract] [Full Text] [Related]

  • 13. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
    Nakamura T, Fujii S, Hoshino J, Saito Y, Mizuno H, Saito Y, Kurabayashi M.
    Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
    [Abstract] [Full Text] [Related]

  • 14. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I, Saruta T, ADVANCE-Combi Study Group.
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [Abstract] [Full Text] [Related]

  • 15. Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stress.
    Arosio E, De Marchi S, Prior M, Rigoni A, Lechi A.
    J Hypertens; 2005 Oct; 23(10):1923-7. PubMed ID: 16148617
    [Abstract] [Full Text] [Related]

  • 16. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Castellano M, Cavaliere G, Nordio G, Pasini F, Zuccato F.
    J Cardiovasc Pharmacol; 1994 Apr; 24 Suppl A():S37-43. PubMed ID: 7603076
    [Abstract] [Full Text] [Related]

  • 18. Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.
    Kjeldsen SE, McInnes GT, Mancia G, Hua TA, Julius S, Weber MA, Coca A, Girerd X, Jamerson K, Larochelle P, Macdonald T, Schmieder RE, Anthony Schork M, Viskoper R, Widimsky J, Zanchetti A.
    Blood Press; 2008 Apr; 17(3):170-7. PubMed ID: 18608200
    [Abstract] [Full Text] [Related]

  • 19. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM, Hilkert R.
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [Abstract] [Full Text] [Related]

  • 20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.